Immunocompromised individuals face ongoing COVID-19 risks despite vaccination, highlighting the need for tailored public health strategies and innovative therapies.
Jade Gambill, BS
Advertisement
Articles by Jade Gambill, BS
Several lymphoma experts discuss the current T-cell lymphoma landscape, the need for new therapies, and ongoing research in the space.
Advertisement
Latest Updated Articles
Safeguarding Vulnerability: COVID-19’s Impact on Immunocompromised Patients With CancerPublished: August 15th 2025 | Updated:
Expanding Horizons in T-Cell Lymphoma Therapy: Focus on Personalized Treatment StrategiesPublished: March 7th 2025 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Atezolizumab/Vaccine Combo May Show Long-Term Survival in ES-SCLC
2
The Latest and Hottest Topics in ADCs: A Discussion With a Chemical Engineer
3
Post-IO Curative Treatment Conversion May Prolong Survival in Liver Cancer
4
Nurse-Led Telehealth Displays Feasibility in Ovarian Cancer Follow-Up
5
